首页> 外文期刊>La Presse Médicale Formation. >Traitement de fond de I'asthme : des fondamentaux aux nouveautes
【24h】

Traitement de fond de I'asthme : des fondamentaux aux nouveautes

机译:哮喘的背景处理:从基本面到新颖性

获取原文
获取原文并翻译 | 示例
           

摘要

Mild-to-moderate asthma treatment: From the fundamentals to the latest developments: Asthma is a chronic inflammatory disease airway disease requiring treatment by inhaled corticosteroids as a means of avoiding exacerbations. Short-acting bronchodilator inhalers are supportive treatments that treat bronchospasms alone. They must always be prescribed in association with long-term, disease-modifying inhaled corticosteroids. Different inhaled corti-costeroid dosing schedules should be proposed and adapted in accordance with asthma severity and the required doses of the inhaled corticosteroids. Each schedule necessitates an action plan adapted to the management of exacerbations'. The role of the patient in the choice of prescription strategy (fixed dose versus on request) is of paramount importance as a means of favoring treatment adherence and compliance. Choice of inhalation device is at least as important as prescription strategy insofar as treatment effectiveness depends on correct and appropriate use. Device manipulation is to be monitored during each consultation.
机译:轻度至中度哮喘治疗:从基本面到最新发展:哮喘是一种慢性炎症性气道疾病,需要吸入皮质类固醇治疗,以避免加重。简短作用支气管扩张剂吸入器是单独治疗支气管腔的支持治疗方法。它们必须始终与长期,疾病改良的吸入皮质类固醇相关。应根据哮喘的严重程度和所需的吸入皮质类固醇的剂量提出不同的吸入皮质类固醇剂量时间表。每个时间表都必须制定一个适合管理管理的行动计划。患者在选择处方策略(固定剂量与要求)中的作用至关重要,这是一种有利于治疗依从性和依从性的手段。在治疗有效性取决于正确和适当的使用的情况下,吸入装置的选择至少与处方策略一样重要。每次咨询期间都应监视设备操作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号